JP Stocks

3695.T Stock Rises 0.12% on April 30, 2026 – GMO Product Platform

April 30, 2026
5 min read

Key Points

3695.T trades at ¥1,641 with +0.12% gain on JPX today

Meyka AI rates B+ with 55% upside forecast to ¥2,547.67

Company faces -40% net income decline but maintains strong cash position of ¥1,327 per share

May 14 earnings announcement critical for assessing recovery trajectory and growth outlook

GMO Product Platform, Inc. (3695.T) traded at ¥1,641 on the JPX today with a modest +0.12% gain, adding ¥2 to its opening price of ¥1,645. The Tokyo-based specialty business services company operates Asia Cloud Panel, a multi-country online survey platform. With a market cap of ¥7.23 billion and 1,400 shares traded, 3695.T stock shows cautious intraday activity. Meyka AI rates this stock with a B+ grade, suggesting a neutral stance. The company faces headwinds from a -43.41% one-year decline, though long-term revenue growth remains positive at 52.93% over ten years.

3695.T Stock Performance and Technical Setup

3695.T stock opened at ¥1,645 and traded within a narrow ¥1,641 to ¥1,645 range today. The 50-day moving average sits at ¥1,700.80, while the 200-day average stands at ¥2,060.03, signaling a downtrend. Year-to-date, 3695.T has declined -23.39%, with a year-low of ¥1,638 and year-high of ¥2,924.

Technical Indicators Show Weakness

The RSI at 38.88 suggests oversold conditions, while MACD remains negative at -19.06. The Stochastic %K at 5.57 indicates strong downward momentum. Bollinger Bands upper band sits at ¥1,677.52, providing resistance. Volume remains light at 1,400 shares versus the 6,140 average, reflecting low institutional interest in 3695.T stock today.

Valuation Metrics and Financial Health

3695.T trades at a P/E ratio of 39.16 with earnings per share of ¥41.90, suggesting elevated valuation relative to earnings. The price-to-sales ratio of 1.06 appears reasonable for a specialty services firm. Book value per share stands at ¥590.01, giving a price-to-book ratio of 2.80, indicating the market values 3695.T stock at nearly 3x tangible assets.

Balance Sheet Strength

The company maintains a healthy current ratio of 1.18 and low debt-to-equity of 0.27, reflecting conservative leverage. Cash per share reaches ¥1,327.33, providing substantial liquidity. However, the dividend yield of 3.63% with ¥59.52 per share payout shows management prioritizes shareholder returns despite earnings pressure.

Growth Outlook and Analyst Consensus

GMO Product Platform faces near-term headwinds with -40.40% net income decline in fiscal 2024 and -50.05% operating cash flow drop. However, long-term fundamentals remain intact with ten-year revenue growth of 52.93% per share. The company’s AI-powered survey platform positions it for recovery as digital transformation accelerates across Asia.

Price Forecast and Rating

Meyka AI’s forecast model projects ¥2,547.67 yearly price target, implying 55.1% upside from current levels. The B+ rating reflects mixed signals: strong DCF valuation (5/5) offset by weak ROE (2/5) and concerning P/E metrics (1/5). Track 3695.T on Meyka for real-time updates. Forecasts are model-based projections and not guarantees.

Market Sentiment and Trading Activity

Trading volume at 1,400 shares represents just 22.8% of average volume, signaling minimal institutional participation in 3695.T stock today. The Money Flow Index at 66.69 suggests accumulation despite price weakness, indicating smart money positioning ahead of earnings.

Liquidation and Positioning

On-Balance Volume at -90,600 reflects net selling pressure, though the Awesome Oscillator at -24.68 shows momentum divergence. The Williams %R at -94.83 indicates extreme oversold conditions, potentially setting up a bounce. Earnings announcement on May 14, 2026 could trigger significant volatility in 3695.T stock as investors reassess growth prospects.

Final Thoughts

3695.T stock trades at ¥1,641 with mixed technical and fundamental signals. While the B+ Meyka grade and 55% upside forecast suggest long-term potential, near-term weakness persists with declining earnings and low trading volume. The company’s strong cash position (¥1,327 per share) and reasonable debt levels provide downside protection. Investors should monitor the May 14 earnings report closely, as it will clarify whether the -40% net income decline represents a temporary setback or structural challenge. The 3.63% dividend yield offers income support, but growth investors may wait for clearer recovery signals before accumulating 3695.T stock.

FAQs

What is the current price and performance of 3695.T stock today?

3695.T trades at ¥1,641 on JPX with +0.12% gain (¥2 change). Year-to-date decline is -23.39%; one-year performance is -43.41%.

What does Meyka AI rate 3695.T stock?

Meyka AI rates 3695.T with B+ grade (70.17 score), suggesting neutral BUY. This factors in S&P 500 comparison, sector performance, financial growth, and analyst consensus. Not financial advice.

What is the price forecast for 3695.T stock?

Meyka AI projects ¥2,547.67 yearly price target (55.1% upside). Three-year forecast: ¥2,451.23; five-year: ¥2,366.37. Model-based projections, not guarantees.

When is GMO Product Platform’s next earnings announcement?

GMO Product Platform reports earnings May 14, 2026. This could trigger volatility as investors reassess growth following -40.40% net income decline in fiscal 2024.

What are the key financial metrics for 3695.T?

P/E ratio: 39.16; price-to-sales: 1.06; price-to-book: 2.80. Market cap: ¥7.23 billion; EPS: ¥41.90; dividend yield: 3.63%. Current ratio: 1.18; debt-to-equity: 0.27.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)